Showing posts with label pharmacutical liability. Show all posts
Showing posts with label pharmacutical liability. Show all posts

Wednesday, September 15, 2010

FEMUR FRACTURE | Panel Recommends Thigh Fracture Warning for Bone Drugs | Actonel, Boniva, and Fosamax

NATIONAL - The American Society of Bone and Mineral Research Femoral Fracture Task Force is recommending that US health regulators rewrite the warning labels for a popular class of osteoporosis drugs called bisphosphonates because of their possible association with atypical femur fractures. Bisphosphonates include drugs sold under the brand names Actonel, Boniva, and Fosamax. 

The task force recommendation was prompted by its finding that the bone drugs might be linked to the rare, but serious, type of thigh bone fracture. The study was released today, and is slated to be published in the Journal of Bone and Mineral Research.

Have you or a loved one suffered a femur fracture after using Actonel, Boniva, or Fosamax?
 
Call the TRIPP LAW FIRM - Personal Injury Law
for an IMMEDIATE teleconference to discuss your rights
We are available 24/7

(888) 392-LAWS (5297)

Injury Attorney G. Alan Tripp, Jr. and
his injury law team are available NOW! 

Don't delay - Call today!

Thursday, August 12, 2010

PATIENTS AT RISK | Avandia | FDA approval | GSK

NATIONAL - According to TIME (8/12, Park) reports that the FDA panel's recent decision to recommend keeping Avandia (rosiglitazone) on the market is "a move worth billions of dollars to GSK but that also may have put millions of patients at risk." The move is also an example "of the drug industry's outmaneuvering FDA regulators," which is "disturbingly common, say both scientists and policymakers who follow drug approval and safety monitoring." FDA critics and industry monitors "charge that the drug-approval process is too easy for pharmaceutical companies to game. It is in some ways an unsurprising development. The FDA serves a public insatiably hungry for new medicines. Yet the agency does not have responsibility for performing safety testing."

Thursday, July 1, 2010

Avastin may cause significant kidney damage in some patients

NATIONAL - Today, The Los Angeles Times reported that Avastin (bevacizumab) "can cause significant kidney damage in some patients," according to a new study.

Researchers, "reporting in this month's issue of the Journal of the American Society of Nephrology...wrote that patients on Avastin were at increased risk of severe protein loss from the kidneys, which can lead to permanent damage."

Altogether, "patients on Avastin were at a fourfold risk for protein loss and kidney damage, depending on dosage and the type of cancer."

www.trippfirm.com  TRIPP LAW FIRM - Personal Injury Law

Wednesday, June 23, 2010

$19.4 MILLION DOLLAR JURY AWARD | Wyeth | Upjohn

The U.S. Supreme Court rejected Pfizer Inc.'s appeal of a ruling that ordered a retrial on how much punitive damages should be awarded to a woman who developed breast cancer after taking the company's hormone replacement therapy drugs.

Pfizer in its appeal argued that a retrial limited to just punitive damages had violated its constitutional right to a jury trial and that the trial judge in the case had improperly admitted the testimony of a scientific expert.

The jury awarded her compensatory damages of $2.7 million and punitive damages of $19.4 million against Wyeth, and $7.8 million against Upjohn.

A U.S. appeals court upheld the jury's award of compensatory damages and said a federal judge had correctly set aside the punitive damages award against Upjohn as a matter of law. The appeals court ordered a new trial on punitive damages involving Wyeth.

Wednesday, March 31, 2010

Yaz ◊ Yasmin ◊ Blood clots ◊ DVT ◊ heart problems

Yaz and Yasmin have a wide range of side effects. Blood clots, DVT, and heart problems just to name a few.

Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems.

Some of the adverse events reported to the U.S. Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyponatremis, hyperkalemia, hyperkalemic arrhythmias, atrial fibrillation, tachycardia, bradycardia, myocardial infarction, stroke, transient ischemic attack, blood clots, embolisms, and sudden death. 

If you have suffered any of these problems after taking Yaz ◊ Yasmin call the TRIPP LAW FIRM – Personal Injury Law for an immediate telephone consultation. We are available 24 hours a day at (888) 392-LAWS (5497). 

http://www.trippfirm.com/   TRIPP LAW FIRM – Personal Injury Law